FEATURED ARTICLES
The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry.
-
Why Site Relationships With Sponsors and CROs Must Evolve Now
Sites are central to drug development — we cannot run a trial without them — yet the industry continues to treat them as tactical, temporary instruments. It’s time to break this cycle, implores Jim Kremidas, executive director, Association of Multisite Research Corporations (AMRC).
-
A Tale Of Two Sites: How FastWave Ran Trials In Distinct Locales
No two sites are the same. Discover how FastWave Medical chose its global sites, and learn best practices on who to partner with and how.
-
Site Payments Are Still a Mess, But Takeda Is Trying To Help
In this article, Heidi Barham, Takeda’s associate director of clinical study site payments, explains how the company is replacing opaque CRO-driven processes with real-time transparency, streamlined startup payments, and a dedicated sponsor-side team that sites can actually reach.